Concepedia
Statistics
Publications
1
Citations
15
H-Index
Active since
2011
R. Lee is an author specializing in her2-positive breast cancer immunotherapy, her2 inhibitors, and her2-positive breast cancer therapy.
Publications per year
2011–2011
A phase I study of the AKT inhibitor (MK-2206) with concurrent trastuzumab and lapatinib in patients with HER2-positive solid tumors.
Hyo S. Han, Charles Swanton, Y. Y. Janjigian et al. · Journal of Clinical Oncology · 2011 · 15 citations
Medicine, Oncology, Pharmacology +16
1–1 of 1